John Akintunde Okeniyi

John Akintunde Okeniyi

Auto-generated profile, based on publicly available information

John Akintunde Okeniyi

Department of paediatrics, Obafemi Awolowo Teaching Hospital, Ile -Ife, Osun State, Nigeria

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2008 in Journal of Affective Disorders
Verified
Journal Article
Closed access
AAAbiodun Olugbenga Adewuya
Abiodun Olugbenga Adewuya
BOBolanle Ola
Bolanle Ola
OAOlutayo O. Aloba
Olutayo O. Aloba
BMBoladale Moyosore Mapayi
Boladale Moyosore Mapayi
JOJohn A.O. Okeniyi
John A.O. Okeniyi

1 March 2007 in Journal of Medicinal Food
Verified
Journal Article
Closed access
JOJohn A.O. Okeniyi
John A.O. Okeniyi
TOTinuade A. Ogunlesi
Tinuade A. Ogunlesi
OOOyeku A. Oyelami
Oyeku A. Oyelami
LALateef A. Adeyemi
Lateef A. Adeyemi
The tropical fruit Carica papaya and its seeds have proven antihelminthic and anti-amoebic activities. To determine the effectiveness of air-dried C. papaya seeds on human intestinal parasitosis, 60 asymptomatic Nigerian children with stool microscopic evidence of intestinal parasites received immediate doses (20 mL) of either an elixir composed with air-dried C. papaya seeds and honey (CPH) or honey alone (placebo) in two randomized treatment groups. Repeat stool microscopic examinations were conducted 7 days postintervention for intestinal parasites. Significantly more subjects given CPH elixir than those given honey had their stools cleared of parasites [23 of 30 (76.7%) vs. five of 30 (16.7%); z = 4.40, P = .0000109]. There were no harmful effects. The stool clearance rate for the various types of parasites encountered was between 71.4% and 100% following CPH elixir treatment compared with 0-15.4% with honey. Thus, air-dried C. papaya seeds are efficacious in treating human intestinal parasites and without significant side effects. Their consumption offers a cheap, natural, harmless, readily available monotherapy and preventive strategy against intestinal parasitosis, especially in tropical communities. Further and large-scale intervention studies to compare C. papaya with standard antiparasitic preparation are desirous.

1 June 2005 in The Journal of Alternative and Complementary Medicine
Verified
Journal Article
Closed access
JOJohn A.O. Okeniyi
John A.O. Okeniyi
OOOlasunkanmi O. Olubanjo
Olasunkanmi O. Olubanjo
TOTinuade A. Ogunlesi
Tinuade A. Ogunlesi
OOOyeku A. Oyelami
Oyeku A. Oyelami
To clinically compare the healing of abscess wounds dressed with either crude undiluted honey or Edinburgh University solution of lime (EUSOL). A prospective clinical randomized study. The Isolation Children's Ward of the Wesley Guild Hospital, Ilesa, an affiliate of the Obafemi Awolowo University, Ile-Ife, Nigeria. Thirty-two (32) Nigerian children with 43 pyomyositis abcesses. All subjects had fresh surgical incision and drainage of the abcesses and a 21-day course of ampicillin plus cloxacillin (Ampiclox) and gentamicin; the wounds were left to close spontaneously with twice-daily wound dressing with packing of the abscess cavity with either honey- or EUSOL-soaked gauze in two randomized treatment groups. The clinical conditions of the wound sites were documented on days 1, 3, 7, and 21 as either clean or dirty, dry or wet, granulation tissue present or absent, and epithelialization present or absent; the length of hospital stay was also measured. Honey-treated wounds demonstrated quicker healing and the length of hospital stay was significantly shorter in patients with honey-treated wounds than those treated with EUSOL (t = 2.45, p = 0.019). Honey is a superior wound dressing agent to EUSOL. Honey is recommended for the dressing of infected wounds, more so in tropical countries, where it is most readily available.

24 February 2006 in Epilepsia
Verified
Journal Article
Closed access
PDF file
AAAbiodun Olugbenga Adewuya
Abiodun Olugbenga Adewuya
SOSaheed B. A. Oseni
Saheed B. A. Oseni
JOJohn A. O. Okeniyi
John A. O. Okeniyi

1 December 2006 in Indian Journal of Pediatrics
Verified
Journal Article
Closed access
PDF file
OTOgunlesi Tinuade
Ogunlesi Tinuade
OJOkeniyi John
Okeniyi John
OSOseni Saheed
Oseni Saheed
OOOyelami Oyeku
Oyelami Oyeku
NFNjokanma Fidelis
Njokanma Fidelis
DODedeke Olabisi
Dedeke Olabisi

15 December 2013 in The Journal of Infection in Developing Countries
Verified
Journal Article
Open access
PDF file
OOOlusola Ojurongbe
Olusola Ojurongbe
OLOlubunmi A Lawal
Olubunmi A Lawal
OAOyindamola Abiodun
Oyindamola Abiodun
JOJohn A Okeniyi
John A Okeniyi
AOAyobami J Oyeniyi
Ayobami J Oyeniyi
OOOyeku A Oyelami
Oyeku A Oyelami
Introduction: The development and spread of Plasmodium falciparum resistance to most commonly used antimalarials remain a major challenge in the control of malaria. Constant monitoring of drug efficacy is an important tool in establishing rational antimalarial drug policies. Methodology: A randomized comparative study was conducted at the Wesley Guild Hospital, Ilesa, Nigeria between February 2010 and September 2011 comparing the efficacy and safety of artemether-lumefantrine (Coartem) and fixed dose of artesunate plus amodiaquine (Larimal) in the treatment of uncomplicated P. falciparum malaria in children betweem 6 and 144 months of age. P. falciparum malaria parasitemia was assessed by microscopy and rapid diagnostic test. Drugs were administered according to age for three days under supervision. The primary efficacy endpoint was a day 28 PCR-corrected parasitological cure. Results: A total of 182 patients were enrolled in the two treatment groups, Coartem (n = 101) and Larimal (n = 81), and tested after 28 days. In the intention-to-treat population, Coartem (n= 101) and Larimal (n= 81) had a PCR-corrected cure rate of 98% and 100% respectively, while in the per-protocol population, Coartem (n = 89) and Larimal (n = 71) both had a PCR-corrected cure rate of 100% at day 28. Although parasite and fever clearance time was faster in the Larimal group, no significant difference was observed between the two drugs. No serious adverse effects were reported. Conclusion: Five years after being introduced in Nigeria, both Coartem and Larimal have been shown to be safe and highly effective in the treatment of uncomplicated P. falciparum malaria in children.